Search results
Results from the WOW.Com Content Network
Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of -23.26% and 63.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for ...
Viridian Therapeutics, Inc. (VRDN) delivered earnings and revenue surprises of 1.15% and 131.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead ...
Here's what else happened today: Disney said it will appoint Bob Iger's successor as CEO by early 2026. Goldman Sachs said investors should prepare for a decade of muted returns in the stock market.
The US stock rally stumbled Monday, with the S&P 500 and Nasdaq 100 retreating from record highs as investors await key inflation data this week and as chipmaker Nvidia shares dropped amid news of ...
For premium support please call: 800-290-4726 more ways to reach us
The facade of the New York Stock Exchange is illuminated on Tuesday, Nov. 19, 2024. ... Shoppers are contending with high prices across the economy and still-high interest rates. ... USA TODAY Sports.
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
The Dow Jones Industrial Average slipped 76 points, or 0.2%, while the Nasdaq composite added 0.4% to its own record set a day earlier. On the losing end of Wall Street was U.S. Steel, which fell 8%.